Sumitomo Life Insurance’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Buy
16,236
+446
+3% +$62.5K 0.05% 119
2025
Q4
$1.94M Buy
15,790
+102
+0.7% +$12.4K 0.05% 130
2025
Q3
$1.74M Sell
15,688
-472
-3% -$53.6K 0.05% 130
2025
Q2
$1.79M Sell
16,160
-1,006
-6% -$107K 0.12% 125
2025
Q1
$1.92M Sell
17,166
-165
-1% -$17K 0.07% 120
2024
Q4
$1.6M Sell
17,331
-491
-3% -$44.2K 0.03% 143
2024
Q3
$1.49M Buy
17,822
+117
+0.7% +$8.93K 0.03% 150
2024
Q2
$1.21M Sell
17,705
-1,839
-9% -$123K 0.03% 162
2024
Q1
$1.43M Sell
19,544
-862
-4% -$66.3K 0.04% 154
2023
Q4
$1.65M Sell
20,406
-1,038
-5% -$80.8K 0.05% 137
2023
Q3
$1.61M Sell
21,444
-279
-1% -$21.5K 0.05% 116
2023
Q2
$1.67M Sell
21,723
-1,848
-8% -$147K 0.07% 113
2023
Q1
$1.96M Sell
23,571
-176
-0.7% -$14.6K 0.16% 96
2022
Q4
$2.04M Sell
23,747
-331
-1% -$26.2K 0.15% 84
2022
Q3
$1.49M Sell
24,078
-2,862
-11% -$180K 0.06% 122
2022
Q2
$1.67M Buy
26,940
+458
+2% +$28.4K 0.05% 122
2022
Q1
$1.57M Sell
26,482
-662
-2% -$42.3K 0.04% 146
2021
Q4
$1.97M Sell
27,144
-730
-3% -$50.3K 0.05% 125
2021
Q3
$1.95M Sell
27,874
-1,179
-4% -$82.8K 0.05% 126
2021
Q2
$2M Sell
29,053
-4,919
-14% -$328K 0.06% 115
2021
Q1
$2.2M Sell
33,972
-1,648
-5% -$106K 0.09% 113
2020
Q4
$2.08M Sell
35,620
-6,488
-15% -$391K 0.09% 116
2020
Q3
$2.66M Sell
42,108
-2,041
-5% -$142K 0.12% 86
2020
Q2
$3.4M Sell
44,149
-5,985
-12% -$459K 0.18% 64
2020
Q1
$3.75M Buy
50,134
+503
+1% +$34.8K 0.27% 51
2019
Q4
$3.23M Buy
49,631
+2,478
+5% +$161K 0.37% 75
2019
Q3
$2.99M Sell
47,153
-6,047
-11% -$395K 0.39% 68
2019
Q2
$3.59M Buy
53,200
+1,889
+4% +$124K 0.42% 64
2019
Q1
$3.34M Sell
51,311
-3,883
-7% -$258K 0.45% 62
2018
Q4
$3.45M Sell
55,194
-490
-0.9% -$34.2K 0.48% 58
2018
Q3
$4.3M Buy
55,684
+20,944
+60% +$1.58M 0.52% 53
2018
Q2
$2.46M Buy
34,740
+8,929
+35% +$631K 0.3% 104
2018
Q1
$1.95M Sell
25,811
-1,137
-4% -$90.4K 0.26% 134
2017
Q4
$1.93M Sell
26,948
-1,308
-5% -$99.3K 0.24% 139
2017
Q3
$2.29M Sell
28,256
-515
-2% -$39.4K 0.29% 114
2017
Q2
$2.04M Buy
28,771
+1,219
+4% +$81.1K 0.27% 127
2017
Q1
$1.87M Sell
27,552
-9,356
-25% -$658K 0.26% 118
2016
Q4
$2.64M Buy
36,908
+820
+2% +$60.9K 0.38% 75
2016
Q3
$2.85M Sell
36,088
-7,643
-17% -$621K 0.42% 59
2016
Q2
$3.65M Sell
43,731
-19,443
-31% -$1.73M 0.5% 52
2016
Q1
$5.8M Sell
63,174
-10,291
-14% -$928K 0.75% 28
2015
Q4
$7.43M Buy
73,465
+2,107
+3% +$219K 0.94% 21
2015
Q3
$7.01M Buy
71,358
+6,929
+11% +$770K 0.93% 18
2015
Q2
$7.54M Sell
64,429
-5,768
-8% -$630K 0.92% 17
2015
Q1
$6.89M Sell
70,197
-21,635
-24% -$2.2M 0.76% 27
2014
Q4
$8.66M Sell
91,832
-1,901
-2% -$197K 0.86% 20
2014
Q3
$9.98M Sell
93,733
-3,406
-4% -$334K 0.98% 16
2014
Q2
$8.05M Sell
97,139
-22,747
-19% -$1.77M 0.77% 25
2014
Q1
$8.49M Sell
119,886
-9,872
-8% -$774K 0.82% 21
2013
Q4
$9.75M Sell
129,758
-23,372
-15% -$1.63M 0.88% 20
2013
Q3
$9.62M Buy
153,130
+19,854
+15% +$1.19M 0.9% 21
2013
Q2
$6.83M Buy
+133,276
New +$6.95M 0.65% 35

Other funds holding GILD

Sumitomo Life Insurance's GILD Position: Q1 2026 in Review

Sumitomo Life Insurance increased its Gilead Sciences (GILD) stake by 2.8% in Q1 2026, buying an estimated $62.5K and bringing the position to 16,236 shares worth $2.26M. The position accounts for 0.05% of the portfolio, ranked #119.

Sumitomo Life Insurance first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.98M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Sumitomo Life Insurance held 16,236 shares of Gilead Sciences worth $2.26M as of Q1 2026.
  • Sumitomo Life Insurance bought 446 Gilead Sciences shares in Q1 2026, an estimated $62.5K.
  • Gilead Sciences made up 0.05% of Sumitomo Life Insurance's portfolio in Q1 2026, its #119 holding.
  • Sumitomo Life Insurance first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Life Insurance's Gilead Sciences position peaked at $9.98M in Q3 2014.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.